Andere Kunden interessierten sich auch für
![Non-Alcoholic Fatty Liver Disease, an Issue of Clinics in Liver Disease]( "Non-Alcoholic Fatty Liver Disease, an Issue of Clinics in Liver Disease")
Non-Alcoholic Fatty Liver Disease, an Issue of Clinics in Liver Disease130,99 €![Nonalcoholic Fatty Liver Disease, an Issue of Clinics in Liver Disease]( "Nonalcoholic Fatty Liver Disease, an Issue of Clinics in Liver Disease")
Nonalcoholic Fatty Liver Disease, an Issue of Clinics in Liver Disease118,99 €![Nash and Nafld, an Issue of Clinics in Liver Disease]( "Nash and Nafld, an Issue of Clinics in Liver Disease")
Nash and Nafld, an Issue of Clinics in Liver Disease130,99 €![Laboratory Monitoring of Gastrointestinal and Hepatobiliary Disease, an Issue of Gastroenterology Clinics of North America]( "Laboratory Monitoring of Gastrointestinal and Hepatobiliary Disease, an Issue of Gastroenterology Clinics of North America")
Laboratory Monitoring of Gastrointestinal and Hepatobiliary Disease, an Issue of Gastroenterology Clinics of North America118,99 €![Liver Pathology, an Issue of Gastroenterology Clinics of North America]( "Liver Pathology, an Issue of Gastroenterology Clinics of North America")
Liver Pathology, an Issue of Gastroenterology Clinics of North America118,99 €![Gastroesophageal Reflux Disease, an Issue of Gastroenterology Clinics of North America]( "Gastroesophageal Reflux Disease, an Issue of Gastroenterology Clinics of North America")
Gastroesophageal Reflux Disease, an Issue of Gastroenterology Clinics of North America118,99 €![Celiac Disease, an Issue of Gastroenterology Clinics of North America]( "Celiac Disease, an Issue of Gastroenterology Clinics of North America")
Celiac Disease, an Issue of Gastroenterology Clinics of North America118,99 €
Together with Consulting Editor Dr. Alan Buchman, Drs. Arun J. Sanyal and Mohammad Siddiqui have put together a comprehensive issue devoted to fatty liver disease for the gastroenterologist. Expert authors have contributed clinical review articles on the following topics: Burden of disease due to NAFLD; Genetic risk factors and disease modifiers of NASH; How to identify the patient with NASH who will progress to cirrhosis; Similarities and Differences between cirrhosis due to NASH versus other etiologies; Impications of NASH as the etiology of end stage liver disease prior to and after liver transplantation; Why do lifestyle recommendations fail in most patients; Rational nutritional therapeutics for NAFLD; Recruitment and retention strategies in long-term trials for NASH; Managing extrahepatic comorbidities in NAFLD; The current status of noninvasive tools for the assessment of NAFLD; and Pharmacological Treatment strategies for NASH. Readers will come away with the information they need to improve outcomes in patients with fatty liver disease.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.